Mode
Text Size
Log in / Sign up

Narrative review evaluates insulin adsorption in ICU infusion systems and suggests priming or alternative materials.

Narrative review evaluates insulin adsorption in ICU infusion systems and suggests priming or altern…
Photo by Markus Spiske / Unsplash
Key Takeaway
Consider using priming or alternative infusion materials to reduce insulin adsorption in ICU settings.

This narrative review synthesizes data from thirty-eight studies to evaluate insulin adsorption within intensive care unit infusion systems. The scope covers comparisons between polyvinyl chloride and di(2-ethylhexyl) phthalate systems versus alternatives such as polyethylene, polypropylene, fluorinated ethylene propylene, SEBS, and TPO. Additionally, the authors assess the impact of priming and preconditioning techniques on early insulin loss.

The analysis reveals that insulin adsorption on PVC results in the highest losses, with effect sizes reaching up to 70%. In contrast, adsorption on alternative materials like PE, PP, and FEP demonstrates significantly lower loss rates. Materials such as SEBS and TPO offer partial improvements over standard PVC systems. Priming and preconditioning techniques are noted to minimize early adsorption and reduce overall loss.

The authors highlight that transitioning toward DEHP-free and non-PVC devices supports green hospital reforms. However, the review does not report specific adverse events, tolerability, or patient safety outcomes. The evidence is observational in nature, and the authors refrain from making causal claims regarding clinical outcomes beyond adsorption metrics.

Practice relevance is framed cautiously. The evidence supports the use of priming techniques and alternative materials to reduce losses. Clinicians should consider these findings when selecting infusion systems, though broader clinical implications remain to be fully defined by future research.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
IntroductionInsulin infusion therapy is critical for glycemic management in intensive care units (ICUs), yet its effectiveness is compromised by adsorption to infusion materials, particularly polyvinyl chloride (PVC) tubing and bags plasticized with di(2-ethylhexyl) phthalate (DEHP). This phenomenon results in underdosing, unstable glucose control, and increased risk of hypo- and hyperglycemia. At the same time, PVC and DEHP raise environmental and toxicological concerns, driving global efforts toward green hospital reforms.AimThis narrative review synthesizes current evidence on insulin adsorption across PVC and DEHP-free infusion systems, evaluating implications for clinical safety, glycemic control, and sustainable healthcare practices.MethodsA Structured Narrative Analysis Review (SNAR) was conducted, with systematic searches in eight databases guided by PICO and SPIDER frameworks. Thirty-eight studies met the inclusion criteria. Data were thematically analyzed using Braun and Clarke’s six-phase method.ResultsInsulin adsorption varied by material, with PVC demonstrating the highest losses (up to 70%), particularly at low flow rates and during the early infusion period. Alternatives such as polyethylene (PE), polypropylene (PP), and fluorinated ethylene propylene (FEP) showed significantly lower adsorption, while SEBS and TPO offered partial improvements but did not eliminate losses. Priming or preconditioning infusion sets with 20 mL of insulin solution consistently minimized early adsorption. Thematic analysis revealed four main domains: (1) insulin adsorption as a clinical safety risk, (2) material-dependent variability, (3) mitigation strategies, and (4) sustainability implications.ConclusionInsulin adsorption on PVC infusion systems is a clinically significant barrier to precise glycemic control in critical care. Evidence supports the use of priming techniques and alternative materials (PE, PP, FEP) to reduce losses. Transitioning toward DEHP-free and non-PVC devices aligns with green hospital reforms, offering dual benefits for patient safety and environmental sustainability.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.